Literature DB >> 9087829

Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma.

H Yanai1, J Nishikawa, Y Mizugaki, N Shimizu, K Takada, K Matsusaki, T Toda, Y Matsumoto, M Tada, K Okita.   

Abstract

BACKGROUND: Although the presence of Epstein-Barr virus has been documented in approximately 7% of patients with gastric carcinoma, the clinical features of Epstein-Barr virus-associated carcinoma have not been well documented. We studied the histologic and endoscopic characteristics of Epstein-Barr virus-associated gastric carcinoma.
METHODS: We tested 124 gastric carcinomas from 117 patients using in situ hybridization for Epstein-Barr virus encoded small RNA1. The histologic and endoscopic findings in the Epstein-Barr virus-associated groups and the negative control groups were analyzed and compared.
RESULTS: Twelve tumors (9.7%) were identified as Epstein-Barr virus associated. These lesions were located mainly in the upper part of the stomach (p < .05) and had a diffuse-type histology (p < .05) compared with those in the control group. Six of seven (85.7%) early Epstein-Barr virus-associated lesions were type 0 IIc (superficial depressed) or a combined type, and 42.9% were accompanied by submucosal nodules of carcinoma with lymphoid stroma. Four of five (80%) advanced Epstein-Barr virus-associated tumors were type 3 (ulcerated without definite limits), thought to be the advanced shape of superficial depressed lesions.
CONCLUSIONS: Epstein-Barr virus-associated gastric carcinomas often appear as superficial depressed or ulcerated lesions in the upper part of the stomach and have a diffuse-type histology with lymphoid infiltration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9087829     DOI: 10.1016/s0016-5107(97)70265-7

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  26 in total

1.  Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma presenting as a submucosal mass: CT findings with pathologic correlation.

Authors:  Sang Won Kim; Hyeong Cheol Shin; Il Young Kim; Chang Jin Kim; Ji-Hye Lee; Chang Kyun Lee; Dong Jun Jeong
Journal:  Korean J Radiol       Date:  2010-10-29       Impact factor: 3.500

2.  Computed tomography findings for a gastric lymphoepithelioma-like carcinoma: How often does it present as a submucosal mass?

Authors:  Cherry Kim; Hyun Jin Kim; Da Hye Son; Young Soo Park; Seong Ho Park; Jong Seok Lee; Ah Young Kim; Hyun Kwon Ha
Journal:  Eur Radiol       Date:  2015-12-01       Impact factor: 5.315

3.  Unusual growth of an Epstein-Barr virus-associated differentiated early-stage gastric carcinoma: A case report.

Authors:  Noriyuki Horiguchi; Tomomitsu Tahara; Tomohiko Kawamura; Masaaki Okubo; Takamitsu Ishizuka; Naoko Nakano; Yoshihito Nakagawa; Mitsuo Nagasaka; Mitsuru Nakagawa; Tetsuya Tsukamoto; Tomoyuki Shibata; Naoki Ohmiya
Journal:  Mol Clin Oncol       Date:  2018-03-05

4.  Clinicopathologic features of early gastric carcinoma with lymphoid stroma and feasibility of endoscopic submucosal dissection.

Authors:  Dong Hun Shin; Gwang Ha Kim; Bong Eun Lee; Jong Wook Lee; Dong Woo Ha; Hye Kyung Jeon; Dong Hoon Baek; Geun Am Song; Sang Jeong Ahn; Do Youn Park
Journal:  Surg Endosc       Date:  2017-04-13       Impact factor: 4.584

Review 5.  Spectrum of Epstein-Barr virus-related diseases: a pictorial review.

Authors:  Eriko Maeda; Masaaki Akahane; Shigeru Kiryu; Nobuyuki Kato; Takeharu Yoshikawa; Naoto Hayashi; Shigeki Aoki; Manabu Minami; Hiroshi Uozaki; Masashi Fukayama; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2009-02-08       Impact factor: 2.374

6.  Long-Term Survival of Patient with Epstein-Barr Virus-Positive Gastric Cancer Treated with Chemotherapy: Case Report.

Authors:  Hideo Yanai; Noboru Yahara; Takumi Furuya; Hiroto Hayashi; Tomoyuki Murakami; Yuzo Shimokawa; Shigenori Sugihara
Journal:  J Gastrointest Cancer       Date:  2016-03

7.  Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy.

Authors:  Hiroki Osumi; Hiroshi Kawachi; Toshiyuki Yoshio; Satoshi Ida; Noriko Yamamoto; Yusuke Horiuchi; Akiyoshi Ishiyama; Toshiaki Hirasawa; Tomohiro Tsuchida; Naoki Hiki; Kengo Takeuchi; Junko Fujisaki
Journal:  J Gastroenterol       Date:  2019-03-02       Impact factor: 7.527

8.  Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms.

Authors:  Hiroshi Uozaki; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  Epstein-Barr virus association is rare in esophageal squamous cell carcinoma.

Authors:  Hideo Yanai; Atsuyoshi Hirano; Keisuke Matsusaki; Toyokazu Kawano; Osamu Miura; Tomoharu Yoshida; Kiwamu Okita; Norio Shimizu
Journal:  Int J Gastrointest Cancer       Date:  2003

10.  Evaluation of epstein-barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay.

Authors:  Atsuyoshi Hirano; Hideo Yanai; Norio Shimizu; Takeshi Okamoto; Yoshitaka Matsubara; Kohtaro Yamamoto; Kiwamu Okita
Journal:  Int J Gastrointest Cancer       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.